SCI Valuation
Is SCI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SCI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SCI (€18.1) is trading above our estimate of fair value (€11.66)
Significantly Below Fair Value: SCI is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SCI?
Other financial metrics that can be useful for relative valuation.
| What is SCI's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | €8.02m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.8x |
| Enterprise Value/EBITDA | 25.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does SCI's PS Ratio compare to its peers?
| Company | PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.6x | ||
MA10 Binect | 0.5x | 9.9% | €7.3m |
XE8 Black Sea Property | 6.4x | n/a | €7.4m |
DG6 DG-Gruppe | 2.9x | n/a | €7.4m |
CORE Coreo | 0.8x | 17.7% | €7.2m |
SCI SCI | 3.6x | n/a | €8.0m |
Price-To-Sales vs Peers: SCI is expensive based on its Price-To-Sales Ratio (3.6x) compared to the peer average (2.6x).
Price to Earnings Ratio vs Industry
How does SCI's PE Ratio compare vs other companies in the DE Capital Markets Industry?
Price-To-Sales vs Industry: SCI is expensive based on its Price-To-Sales Ratio (3.6x) compared to the German Capital Markets industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is SCI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.6x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate SCI's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.